The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Stimulation of Bone Formation in Vitro and in Rodents by Statins
Abstract
Osteoporosis and other diseases of bone loss are a major public health problem. Here it is shown that the statins, drugs widely used for lowering serum cholesterol, also enhance new bone formation in vitro and in rodents. This effect was associated with increased expression of the bone morphogenetic protein–2 ( BMP-2 ) gene in bone cells. Lovastatin and simvastatin increased bone formation when injected subcutaneously over the calvaria of mice and increased cancellous bone volume when orally administered to rats. Thus, in appropriate doses, statins may have therapeutic applications for the treatment of osteoporosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Increased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6
Jilka, R. L., Hangoc, G., Girasole, G., Passeri, G., Williams, D. C., Abrams, J. S., Boyce, B., Broxmeyer, H., & Manolagas, S. C. (1992) · Science · doi:10.1126/science.1621100 · Cited by 1,442
Self-citationLaw, M. R., Wald, N. J., & Thompson, S. G. (1994) · BMJ · doi:10.1136/bmj.308.6925.367 · Cited by 1,210
Luckman, S. P., Hughes, D. E., Coxon, F. P., Russell, R. G. G., & Dr. Rogers, M. J. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.4.581 · Cited by 1,176
Fisher, J. E., Rogers, M. J., Halasy, J. M., Luckman, S. P., Hughes, D. E., Masarachia, P. J., Wesolowski, G., Russell, R. G. G., Rodan, G. A., & Reszka, A. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.133 · Cited by 676
Perspectives: How many women have osteoporosis now?
Dr. Melton, J. L. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100202 · Cited by 595
Gowen, M., & Mundy, G. R. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2478 · Cited by 476
Self-citationThe Value of Lowering Cholesterol after Myocardial Infarction
Rossouw, J. E., Lewis, B., & Rifkind, B. M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199010183231606 · Cited by 410
Effects of Interleukin-1 on Bone Turnover in Normal Mice*
BOYCE, B. F., AUFDEMORTE, T. B., GARRETT, I. R., YATES, A. J. P., & MUNDY, G. R. (1989) · Endocrinology · doi:10.1210/endo-125-3-1142 · Cited by 363
Self-citationRao, S., Porter, D. C., Chen, X., Herliczek, T., Lowe, M., & Keyomarsi, K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.7797 · Cited by 345
Harris, S. E., Bonewald, L. F., Harris, M. A., Sabatini, M., Dallas, S., Feng, J. Q., Ghosh-Choudhury, N., Wozney, J., & Mundy, G. R. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090611 · Cited by 325
Self-citation
Cited by
PLEIOTROPIC EFFECTS OF STATINS
Liao, J. K., & Laufs, U. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095748 · Cited by 1,994
Therapeutic Approaches to Bone Diseases
Rodan, G. A., & Martin, T. J. (2000) · Science · doi:10.1126/science.289.5484.1508 · Cited by 1,767
Structural mechanism for statin inhibition of HMG-CoA reductase
Istvan, E. S., & Deisenhofer, J. (2001) · Science · doi:10.1126/science.1059344 · Cited by 1,644
Periodontitis and cardiovascular diseases: Consensus report
Sanz, M., Marco del Castillo, A., Jepsen, S., Gonzalez‐Juanatey, J. R., D’Aiuto, F., Bouchard, P., Chapple, I., Dietrich, T., Gotsman, I., Graziani, F., et al. (2020) · Journal of Clinical Periodontology · doi:10.1111/jcpe.13189 · Cited by 1,482
“, 2006) can promote bone formation (Garrett, Gutierrez, & Mundy, 2001; Liu et al., 2012; Mundy et al., 1999; Viereck et al., 2005), can inhibit matrix metalloproteinases (MMPs) (Koh et al.”
BackgroundPleiotropic Effects of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors
Takemoto, M., & Liao, J. K. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq1101.098486 · Cited by 1,272
Bone Formation and Inflammation in Cardiac Valves
Mohler, E. R., Gannon, F., Reynolds, C., Zimmerman, R., Keane, M. G., & Kaplan, F. S. (2001) · Circulation · doi:10.1161/01.cir.103.11.1522 · Cited by 1,049
Weitz-Schmidt, G., Welzenbach, K., Brinkmann, V., Kamata, T., Kallen, J., Bruns, C., Cottens, S., Takada, Y., & Hommel, U. (2001) · Nature Medicine · doi:10.1038/89058 · Cited by 1,041
Walter, D. H., Rittig, K., Bahlmann, F. H., Kirchmair, R., Silver, M., Murayama, T., Nishimura, H., Losordo, D. W., Asahara, T., & Isner, J. M. (2002) · Circulation · doi:10.1161/01.cir.0000018166.84319.55 · Cited by 918
Ornitz, D. M., & Marie, P. J. (2002) · Genes & Development · doi:10.1101/gad.990702 · Cited by 905
Environment-mediated drug resistance: A major contributor to minimal residual disease
Meads, M. B., Gatenby, R. A., & Dalton, W. S. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2714 · Cited by 892
“Importantly, this finding contradicts extensive preclinical work in both in vitro and in vivo models of bone metabolism that concluded that statins inhibit bone resorption, a hallmark of cancers that localize to bone and an indication of a co-opted bone marrow microenvironmen”
ResultFSH Directly Regulates Bone Mass
Sun, L., Peng, Y., Sharrow, A. C., Iqbal, J., Zhang, Z., Papachristou, D. J., Zaidi, S., Zhu, L.-L., Yaroslavskiy, B. B., Zhou, H., et al. (2006) · Cell · doi:10.1016/j.cell.2006.01.051 · Cited by 723
HMG-CoA reductase inhibitor mobilizes bone marrow–derived endothelial progenitor cells
Llevadot, J., Murasawa, S., Kureishi, Y., Uchida, S., Masuda, H., Kawamoto, A., Walsh, K., Isner, J. M., & Asahara, T. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13131 · Cited by 709
Yamaguchi, A., Komori, T., & Suda, T. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.4.0403 · Cited by 696
Treatment of postmenopausal osteoporosis
Delmas, P. D. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08827-x · Cited by 681
Osteoblast-derived VEGF regulates osteoblast differentiation and bone formation during bone repair
Hu, K., & Olsen, B. R. (2016) · Journal of Clinical Investigation · doi:10.1172/jci82585 · Cited by 668
Calcium/Vitamin D Supplementation and Cardiovascular Events
Hsia, J., Heiss, G., Ren, H., Allison, M., Dolan, N. C., Greenland, P., Heckbert, S. R., Johnson, K. C., Manson, J. E., Sidney, S., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.673491 · Cited by 662
MOHAN, S., & BAYLINK, D. J. (1991) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-199102000-00004 · Cited by 519
Gimble, J. M., Zvonic, S., Floyd, Z. E., Kassem, M., & Nuttall, M. E. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20777 · Cited by 495
Pharmacological Actions of Statins: A Critical Appraisal in the Management of Cancer
Gazzerro, P., Proto, M. C., Gangemi, G., Malfitano, A. M., Ciaglia, E., Pisanti, S., Santoro, A., Laezza, C., & Bifulco, M. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.004994 · Cited by 457
HMG-CoA Reductase Inhibitors and the Risk of Fractures
Meier, C. R. (2000) · JAMA · doi:10.1001/jama.283.24.3205 · Cited by 445
A novel anti-inflammatory role for simvastatin in inflammatory arthritis.
Leung, B. P., Sattar, N., Crilly, A., Prach, M., McCarey, D. W., Payne, H., Madhok, R., Campbell, C., Gracie, J. A., Liew, F. Y., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1524 · Cited by 434
Aortic calcification and the risk of osteoporosis and fractures.
Schulz, E., Arfai, K., Liu, X., Sayre, J., & Gilsanz, V. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030964 · Cited by 429
Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis
Capoulade, R., Chan, K. L., Yeang, C., Mathieu, P., Bossé, Y., Dumesnil, J. G., Tam, J. W., Teo, K. K., Mahmut, A., Yang, X., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.07.020 · Cited by 417
HMG-CoA Reductase Inhibitors and the Risk of Hip Fractures in Elderly Patients
Wang, P. S. (2000) · JAMA · doi:10.1001/jama.283.24.3211 · Cited by 416
Osteoblast proliferation and maturation by bisphosphonates
Im, G.-I., Qureshi, S. A., Kenney, J., Rubash, H. E., & Shanbhag, A. S. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2003.11.024 · Cited by 393
Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women
Chan, K. A., Andrade, S. E., Boles, M., Buist, D. S., Chase, G. A., Donahue, J. G., Goodman, M. J., Gurwitz, J. H., LaCroix, A. Z., & Platt, R. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02400-4 · Cited by 391
A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases
Yin, J. J., Mohammad, K. S., Käkönen, S. M., Harris, S., Wu-Wong, J. R., Wessale, J. L., Padley, R. J., Garrett, I. R., Chirgwin, J. M., & Guise, T. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1830978100 · Cited by 381
Self-citationInhibition of fracture healing
Gaston, M. S., & Simpson, A. H. R. W. (2007) · The Journal of Bone and Joint Surgery. British volume · doi:10.1302/0301-620x.89b12.19671 · Cited by 380
Gender differences in cardiovascular disease
Gao, Z., Chen, Z., Sun, A., & Deng, X. (2019) · Medicine in Novel Technology and Devices · doi:10.1016/j.medntd.2019.100025 · Cited by 373
Simvastatin Promotes Osteoblast Differentiation and Mineralization in MC3T3-E1 Cells
Maeda, T., Matsunuma, A., Kawane, T., & Horiuchi, N. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4232 · Cited by 363
Statins as anti-inflammatory agents
Weitz-Schmidt, G. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02077-1 · Cited by 354
Inflammatory, Metabolic, and Genetic Mechanisms of Vascular Calcification
Demer, L. L., & Tintut, Y. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.113.302070 · Cited by 353
Bone Morphogenetic Protein-2 Stimulates Runx2 Acetylation
Jeon, E.-J., Lee, K.-Y., Choi, N.-S., Lee, M.-H., Kim, H.-N., Jin, Y.-H., Ryoo, H.-M., Choi, J.-Y., Yoshida, M., Nishino, N., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512494200 · Cited by 343
Non-lipid-related effects of statins
Bellosta, S., Fed, N., Bernini, F., Paoletti, R., & Corsini, A. (2000) · Annals of Medicine · doi:10.3109/07853890008998823 · Cited by 333
Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro
Garrett, I. R., Chen, D., Gutierrez, G., Zhao, M., Escobedo, A., Rossini, G., Harris, S. E., Gallwitz, W., Kim, K. B., Hu, S., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16198 · Cited by 328
Self-citationOral statins and increased bone-mineral density in postmenopausal women
Edwards, C., Hart, D., & Spector, T. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02408-9 · Cited by 326
Prevention and management of osteoporosis
McClung, M. R. (2003) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/s1521-690x(02)00080-5 · Cited by 321
Bellamy, M. F., Pellikka, P. A., Klarich, K. W., Tajik, A. J., & Enriquez-Sarano, M. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02496-8 · Cited by 321
Siddappa, R., Licht, R., van Blitterswijk, C., & de Boer, J. (2007) · Journal of Orthopaedic Research · doi:10.1002/jor.20402 · Cited by 320
Pleiotropic Effects of Statins: Lipid Reduction and Beyond
McFarlane, S. I. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.4.1451 · Cited by 314
Wnt/β-catenin signaling activates bone morphogenetic protein 2 expression in osteoblasts
Zhang, R., Oyajobi, B. O., Harris, S. E., Chen, D., Tsao, C., Deng, H.-W., & Zhao, M. (2013) · Bone · doi:10.1016/j.bone.2012.09.029 · Cited by 305
Self-citationAtherogenic High-Fat Diet Reduces Bone Mineralization in Mice
Parhami, F., Tintut, Y., Beamer, W. G., Gharavi, N., Goodman, W., & Demer, L. L. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.1.182 · Cited by 302
Ghosh-Choudhury, N., Abboud, S. L., Nishimura, R., Celeste, A., Mahimainathan, L., & Choudhury, G. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205053200 · Cited by 299
Molecular, Endocrine, and Genetic Mechanisms of Arterial Calcification
Doherty, T. M., Fitzpatrick, L. A., Inoue, D., Qiao, J.-H., Fishbein, M. C., Detrano, R. C., Shah, P. K., & Rajavashisth, T. B. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0015 · Cited by 299
A Brief Historical Perspective on Dental Implants, Their Surface Coatings and Treatments
Abraham, C. M. (2014) · The Open Dentistry Journal · doi:10.2174/1874210601408010050 · Cited by 298
Mansukhani, A., Bellosta, P., Sahni, M., & Basilico, C. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.149.6.1297 · Cited by 295
Statins and Cardiovascular Diseases: From Cholesterol Lowering to Pleiotropy
Zhou, Q., & Liao, J. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209787315684 · Cited by 294
Implant surface characteristics and their effect on osseointegration
Barfeie, A., Wilson, J., & Rees, J. (2015) · British Dental Journal · doi:10.1038/sj.bdj.2015.171 · Cited by 292
Osteoporosis and Cardiovascular Disease: Brittle Bones and Boned Arteries, Is There a Link?
McFarlane, S. I., Muniyappa, R., Shin, J. J., Bahtiyar, G., & Sowers, J. R. (2004) · Endocrine · doi:10.1385/endo:23:1:01 · Cited by 289
von Knoch, F., Jaquiery, C., Kowalsky, M., Schaeren, S., Alabre, C., Martin, I., Rubash, H. E., & Shanbhag, A. S. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.04.059 · Cited by 287
Sugiyama, M., Kodama, T., Konishi, K., Abe, K., Asami, S., & Oikawa, S. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2697 · Cited by 285
Lactoferrin Is a Potent Regulator of Bone Cell Activity and Increases Bone Formation in Vivo
Cornish, J., Callon, K. E., Naot, D., Palmano, K. P., Banovic, T., Bava, U., Watson, M., Lin, J.-M., Tong, P. C., Chen, Q., et al. (2004) · Endocrinology · doi:10.1210/en.2003-1307 · Cited by 282
Neuroprotection mediated by changes in the endothelial actin cytoskeleton
Laufs, U., Endres, M., Stagliano, N., Amin-Hanjani, S., Chui, D.-S., Yang, S.-X., Simoncini, T., Yamada, M., Rabkin, E., Allen, P. G., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9639 · Cited by 282
Chiba, H., Uehara, M., Wu, J., Wang, X., Masuyama, R., Suzuki, K., Kanazawa, K., & Ishimi, Y. (2003) · The Journal of Nutrition · doi:10.1093/jn/133.6.1892 · Cited by 273
Use of Statins and Risk of Fractures
van Staa, T.-P. (2001) · JAMA · doi:10.1001/jama.285.14.1850 · Cited by 271
Periodontitis and Cardiovascular Diseases. Consensus Report
Sanz, M., Del Castillo, A. M., Jepsen, S., Gonzalez-Juanatey, J. R., D’Aiuto, F., Bouchard, P., Chapple, I., Dietrich, T., Gotsman, I., Graziani, F., et al. (2020) · Global Heart · doi:10.5334/gh.400 · Cited by 271
Beyond lipid lowering: the role of statins in vascular protection
Liao, J. K. (2002) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00195-x · Cited by 266
Laufs, U., Endres, M., Custodis, F., Gertz, K., Nickenig, G., Liao, J. K., & Böhm, M. (2000) · Circulation · doi:10.1161/01.cir.102.25.3104 · Cited by 265
Calabrese, E. J. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2008.03243.x · Cited by 262
Induction of osteoblast differentiation indices by statins in MC3T3‐E1 cells
Maeda, T., Matsunuma, A., Kurahashi, I., Yanagawa, T., Yoshida, H., & Horiuchi, N. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20074 · Cited by 256
Cellular Mechanisms of Aortic Valve Calcification
Leopold, J. A. (2012) · Circulation: Cardiovascular Interventions · doi:10.1161/circinterventions.112.971028 · Cited by 255
Smith, J. G., Luk, K., Schulz, C.-A., Engert, J. C., Do, R., Hindy, G., Rukh, G., Dufresne, L., Almgren, P., Owens, D. S., et al. (2014) · JAMA · doi:10.1001/jama.2014.13959 · Cited by 238
Osteoblasts in osteoporosis: Past, emerging, and future anabolic targets
Marie, P. J., & Kassem, M. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0132 · Cited by 234
Oxytocin controls differentiation of human mesenchymal stem cells and reverses osteoporosis
Elabd, C., Basillais, A., Beaupied, H., Breuil, V., Wagner, N., Scheideler, M., Zaragosi, L.-E., Massiéra, F., Lemichez, E., Trajanoski, Z., et al. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0127 · Cited by 202
Osteoblast Autonomous Pi Regulation via Pit1 Plays a Role in Bone Mineralization
Yoshiko, Y., Candeliere, G. A., Maeda, N., & Aubin, J. E. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00104-07 · Cited by 140
Pitavastatin: Efficacy and Safety Profiles of A Novel Synthetic HMG‐CoA Reductase Inhibitor
Kajinami, K., Takekoshi, N., & Saito, Y. (2003) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2003.tb00116.x · Cited by 136
Su, J.-L., Chiou, J., Tang, C.-H., Zhao, M., Tsai, C.-H., Chen, P.-S., Chang, Y.-W., Chien, M.-H., Peng, C.-Y., Hsiao, M., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.087122 · Cited by 121
Self-citationOsteoclasts secrete non-bone derived signals that induce bone formation
Karsdal, M. A., Neutzsky-Wulff, A. V., Dziegiel, M. H., Christiansen, C., & Henriksen, K. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.11.168 · Cited by 112
Ahn, K. S., Sethi, G., Chaturvedi, M. M., & Aggarwal, B. B. (2008) · International Journal of Cancer · doi:10.1002/ijc.23745 · Cited by 109
Cholesterol-independent Effects of Statins and New Therapeutic Targets: Ischemic Stroke and Dementia
Miida, T., Hirayama, S., & Nakamura, Y. (2004) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.11.253 · Cited by 97
Aspenberg, P. (2005) · Acta Orthopaedica · doi:10.1080/17453670510045318 · Cited by 97
“There is clear evidence for improved bone formation in rats (Mundy et al. 1999), and there has been only one single study in which simvastatin treatment was found to significantly enhance fracture repair, as measured mechanically in mice (Skoglund et al. 2002).”
BackgroundFuruya, Y., Inagaki, A., Khan, M., Mori, K., Penninger, J. M., Nakamura, M., Udagawa, N., Aoki, K., Ohya, K., Uchida, K., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.426080 · Cited by 77
“Bone formation is regulated by cytokines and factors inducing differentiation and mineralization of osteoblasts such as bone morphogenetic proteins (BMPs) (19), parathyroid hormone (PTH) (20), statins (21), Wingless-type (Wnt) (22), growth hormone (23), and insulin-like growth factor (IGF)-1 (24).”
BackgroundControlled Release Scaffolds for Bone Tissue Engineering
Cartmell, S. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21431 · Cited by 66
Oka, S., Matsumoto, T., Kubo, S., Matsushita, T., Sasaki, H., Nishizawa, Y., Matsuzaki, T., Saito, T., Nishida, K., Tabata, Y., et al. (2013) · Tissue Engineering Part A · doi:10.1089/ten.tea.2012.0325 · Cited by 57
Adiponectin signaling and its role in bone metabolism
Pal China, S., Sanyal, S., & Chattopadhyay, N. (2018) · Cytokine · doi:10.1016/j.cyto.2018.06.012 · Cited by 53
Statins as modulators of bone formation
Edwards, C. J., & Spector, T. D. (2002) · Arthritis Research & Therapy · doi:10.1186/ar399 · Cited by 53
Sadie-Van Gijsen, H., Hough, F. S., & Ferris, W. F. (2013) · Bone · doi:10.1016/j.bone.2013.06.016 · Cited by 48
Krauth, D., Anglemyer, A., Philipps, R., & Bero, L. (2014) · PLoS Biology · doi:10.1371/journal.pbio.1001770 · Cited by 36
HSP90β promotes osteoclastogenesis by dual-activation of cholesterol synthesis and NF-κB signaling
Cheng, H.-M., Xing, M., Zhou, Y.-P., Zhang, W., Liu, Z., Li, L., Zheng, Z., Ma, Y., Li, P., Liu, X., et al. (2023) · Cell Death & Differentiation · doi:10.1038/s41418-022-01071-3 · Cited by 34
“Cholesterol lowering drugs greatly reduce the differentiation and activity of osteoclasts [11, 12], thereby reducing the fracture risk associated with OP [13].”
BackgroundMiyajima, C., Hayakawa, Y., Inoue, Y., Nagasaka, M., & Hayashi, H. (2022) · Pharmaceuticals · doi:10.3390/ph15081015 · Cited by 17
“Therefore, lipophilic statins have been reported to have effects other than lowering cholesterol, such as promoting angiogenesis via nitric oxide [17], bone formation [18], and anti-inflammatory effects [19].”
BackgroundDrug Delivery Based on Nanotechnology for Target Bone Disease
Yang, X., Chen, S., Liu, X., Yu, M., & Liu, X. (2019) · Current Drug Delivery · doi:10.2174/1567201816666190917123948 · Cited by 15
Metadata
- Authors
- Mundy, G., Garrett, R., Harris, S., Chan, J., Chen, D., Rossini, G., Boyce, B., Zhao, M., & Gutierrez, G.
- Venue
- Science
- Published
- 1999-12-03
- Volume
- 286
- Issue
- 5446
- Pages
- 1946-1949
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2020364703
- Cited by
- 1,774
- References
- 18
- FWCI
- 20.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.